MktsMarkets

Exponent, Inc.
NASDAQ: EXPOKey statistics
EXPO News
Stories mentioning EXPO from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q2 '26Apr 3 | Q1 '26Jan 2 | Q4 '25Oct 3 | Q3 '25Jul 4 | Q2 '25Apr 4 | Q1 '25Jan 3 | Q3 '24Sep 27 | Q2 '24Jun 28 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 166,303 | 147,425 | 147,120 | 141,962 | 145,507 | 136,766 | 136,279 | 140,536 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | ||||||||
| Total Operating Expenses | 124,924 | 118,285 | 118,082 | 124,785 | 101,075 | 109,513 | 110,432 | 104,792 |
| Operating Income (Loss) | 41,379 | 29,140 | 29,038 | 17,177 | 44,432 | 27,253 | 25,847 | 35,744 |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | (758.00) | 3,028 | 7,267 | 17,294 | (9,386) | 1,490 | 7,531 | 1,707 |
| Pretax Income | 42,339 | 34,105 | 38,617 | 36,815 | 37,760 | 31,328 | 35,937 | 39,682 |
| Tax Provision | 12,770 | 9,343 | 10,573 | 10,262 | 11,110 | 7,739 | 9,893 | 10,455 |
| Net Income (Loss) | 29,569 | 24,762 | 28,044 | 26,553 | 26,650 | 23,589 | 26,044 | 29,227 |
| Earnings Per Share (Basic) | 0.59 | 0.49 | 0.55 | 0.52 | 0.52 | 0.46 | 0.51 | 0.57 |
| Earnings Per Share (Diluted) | 0.59 | 0.48 | 0.55 | 0.52 | 0.52 | 0.46 | 0.50 | 0.57 |
| Weighted Average Shares Outstanding (Basic) | 49,790 | 50,904 | 50,872 | 51,185 | 51,283 | 51,129 | 51,177 | 51,111 |
| Weighted Average Shares Outstanding (Diluted) | 50,119 | 51,244 | 51,179 | 51,502 | 51,650 | 51,569 | 51,622 | 51,517 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About EXPO
Exponent, Inc. (NASDAQ: EXPO) is a stock listed on the Nasdaq Stock Market under the ticker symbol EXPO. It last traded at $88.18 (Nov 16, 2026, 9:33 AM ET), up 1.0% on the day. That gives Exponent a market capitalisation of $4.2B and a price-to-earnings ratio of 36.2.
Over the past 52 weeks EXPO has traded between $51.91 and $90.51.
Revenue for the quarter ended Apr 3, 2026 was $166.3M; net income $29.6M. Revenue was up 14.3% from $145.5M in the quarter ended Apr 4, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Apr 3, 2026 | $166.3M | $29.6M | 17.8% |
| Jan 2, 2026 | $147.4M | $24.8M | 16.8% |
| Oct 3, 2025 | $147.1M | $28.0M | 19.1% |
| Jul 4, 2025 | $142.0M | $26.6M | 18.7% |
From Exponent’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…